BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dokmak A, Almeqdadi M, Trivedi H, Krishnan S. Rise of sodium-glucose cotransporter 2 inhibitors in the management of nonalcoholic fatty liver disease. World J Hepatol 2019; 11(7): 562-573 [PMID: 31388398 DOI: 10.4254/wjh.v11.i7.562]
URL: https://www.wjgnet.com/1948-5182/full/v11/i7/562.htm
Number Citing Articles
1
Rehab F. Abdel-Rahman. Non-alcoholic fatty liver diseaseAsian Pacific Journal of Tropical Biomedicine 2022; 12(3): 99 doi: 10.4103/2221-1691.338919
2
Amélio F. Godoy-Matos, Cynthia Melissa Valério, Wellington S. Silva Júnior, João Marcello de Araujo-Neto, Marcello Casaccia Bertoluci. 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetesDiabetology & Metabolic Syndrome 2024; 16(1) doi: 10.1186/s13098-024-01259-2
3
Hirsh D. Trivedi, Jaspreet Suri, Daheun Oh, Jeffrey Schwartz, Daniela Goyes, Rajab Idriss, Michael P. Curry, Michelle Lai. The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care populationAnnals of Hepatology 2021; 24: 100336 doi: 10.1016/j.aohep.2021.100336
4
Paola Dongiovanni, Erika Paolini, Alberto Corsini, Cesare R. Sirtori, Massimiliano Ruscica. Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approachesEuropean Journal of Clinical Investigation 2021; 51(7) doi: 10.1111/eci.13519
5
Amr Dokmak, Blanca Lizaola-Mayo, Hirsh D. Trivedi. The Impact of Nonalcoholic Fatty Liver Disease in Primary Care: A Population Health PerspectiveThe American Journal of Medicine 2021; 134(1): 23 doi: 10.1016/j.amjmed.2020.08.010
6
Mazhar Hussain, Muhammad Zafar Majeed Babar, Saba Tariq, Muhammad Irfan Ahmad, Lubna Akhtar. Therapeutic outcome of dapagliflozin on various parameters in non-alcoholic fatty liver disease (NAFLD) patientsInternational Journal of Diabetes in Developing Countries 2022; 42(2): 290 doi: 10.1007/s13410-021-00980-2
7
Amélio F. Godoy-Matos, Wellington S. Silva Júnior, Cynthia M. Valerio. NAFLD as a continuum: from obesity to metabolic syndrome and diabetesDiabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00570-y
8
György M. Buzás. Helicobacter pylori and non-alcoholic fatty liver diseaseMinerva Gastroenterologica e Dietologica 2020; 66(3) doi: 10.23736/S1121-421X.20.02671-9